The complex role of NRF2 in cancer

A genomic view

Brandon John Praslicka, Michael John Kerins, Aikseng Ooi

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Heterotrophs are regularly exposed to harmful xenobiotics from their diet and from environmental exposure. As such, systems to counteract the negative consequences brought on by this exposure have evolved since the dawn of heterotrophic nutrition. In mammalian cells, the CNC transcription factor, NRF2, plays a crucial role in counteracting the harmful effects of xenobiotics exposure. In response to increased electrophilic and oxidative stresses, NRF2 upregulates a wide array of target genes involved in various cellular processes to restore cellular homeostasis. Consequently, NRF2 activation is traditionally regarded as cancer preventative and cytoprotective. However, recent cancer genome sequencing efforts have uncovered a significant overrepresentation of somatic mutations that drive a sustained NRF2 activation phenotype in cancer. These mutations share similar features to somatic mutations in tumor suppressors and oncogenes, indicating that NRF2 activation is positively selected for during tumor growth. Additionally, genome wide determination of NRF2 target genes identified new target genes involved in proliferation and differentiation, metabolism, apoptosis, and DNA damage repair. NRF2 activation in cancer cells has also been correlated with chemo- and radio- therapy resistance and an overall poorer patient prognosis. Taken together, these characteristics of NRF2 function have established a need to better understand the full scope of the NRF2 regulatory network. In this review we discuss recent discoveries in the NRF2 field that were enabled by advances in genomic and computational biology methods and outline possible future endeavors.

Original languageEnglish (US)
Pages (from-to)37-45
Number of pages9
JournalCurrent Opinion in Toxicology
Volume1
DOIs
StatePublished - 2016

Fingerprint

Genes
Chemical activation
Xenobiotics
Neoplasms
Nutrition
Tumors
Mutation
Cells
Oxidative stress
Genome
Metabolism
Environmental Exposure
Computational Biology
Radio
Oncogenes
Repair
Transcription Factors
DNA Repair
DNA Damage
Apoptosis

Keywords

  • Cancer
  • CUL3
  • KEAP1
  • NRF2
  • Somatic mutations

ASJC Scopus subject areas

  • Toxicology

Cite this

The complex role of NRF2 in cancer : A genomic view. / Praslicka, Brandon John; Kerins, Michael John; Ooi, Aikseng.

In: Current Opinion in Toxicology, Vol. 1, 2016, p. 37-45.

Research output: Contribution to journalReview article

Praslicka, Brandon John ; Kerins, Michael John ; Ooi, Aikseng. / The complex role of NRF2 in cancer : A genomic view. In: Current Opinion in Toxicology. 2016 ; Vol. 1. pp. 37-45.
@article{d37092e9c3334ef6962b6b1ea6fc5b68,
title = "The complex role of NRF2 in cancer: A genomic view",
abstract = "Heterotrophs are regularly exposed to harmful xenobiotics from their diet and from environmental exposure. As such, systems to counteract the negative consequences brought on by this exposure have evolved since the dawn of heterotrophic nutrition. In mammalian cells, the CNC transcription factor, NRF2, plays a crucial role in counteracting the harmful effects of xenobiotics exposure. In response to increased electrophilic and oxidative stresses, NRF2 upregulates a wide array of target genes involved in various cellular processes to restore cellular homeostasis. Consequently, NRF2 activation is traditionally regarded as cancer preventative and cytoprotective. However, recent cancer genome sequencing efforts have uncovered a significant overrepresentation of somatic mutations that drive a sustained NRF2 activation phenotype in cancer. These mutations share similar features to somatic mutations in tumor suppressors and oncogenes, indicating that NRF2 activation is positively selected for during tumor growth. Additionally, genome wide determination of NRF2 target genes identified new target genes involved in proliferation and differentiation, metabolism, apoptosis, and DNA damage repair. NRF2 activation in cancer cells has also been correlated with chemo- and radio- therapy resistance and an overall poorer patient prognosis. Taken together, these characteristics of NRF2 function have established a need to better understand the full scope of the NRF2 regulatory network. In this review we discuss recent discoveries in the NRF2 field that were enabled by advances in genomic and computational biology methods and outline possible future endeavors.",
keywords = "Cancer, CUL3, KEAP1, NRF2, Somatic mutations",
author = "Praslicka, {Brandon John} and Kerins, {Michael John} and Aikseng Ooi",
year = "2016",
doi = "10.1016/j.cotox.2016.09.003",
language = "English (US)",
volume = "1",
pages = "37--45",
journal = "Current Opinion in Toxicology",
issn = "2468-2020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The complex role of NRF2 in cancer

T2 - A genomic view

AU - Praslicka, Brandon John

AU - Kerins, Michael John

AU - Ooi, Aikseng

PY - 2016

Y1 - 2016

N2 - Heterotrophs are regularly exposed to harmful xenobiotics from their diet and from environmental exposure. As such, systems to counteract the negative consequences brought on by this exposure have evolved since the dawn of heterotrophic nutrition. In mammalian cells, the CNC transcription factor, NRF2, plays a crucial role in counteracting the harmful effects of xenobiotics exposure. In response to increased electrophilic and oxidative stresses, NRF2 upregulates a wide array of target genes involved in various cellular processes to restore cellular homeostasis. Consequently, NRF2 activation is traditionally regarded as cancer preventative and cytoprotective. However, recent cancer genome sequencing efforts have uncovered a significant overrepresentation of somatic mutations that drive a sustained NRF2 activation phenotype in cancer. These mutations share similar features to somatic mutations in tumor suppressors and oncogenes, indicating that NRF2 activation is positively selected for during tumor growth. Additionally, genome wide determination of NRF2 target genes identified new target genes involved in proliferation and differentiation, metabolism, apoptosis, and DNA damage repair. NRF2 activation in cancer cells has also been correlated with chemo- and radio- therapy resistance and an overall poorer patient prognosis. Taken together, these characteristics of NRF2 function have established a need to better understand the full scope of the NRF2 regulatory network. In this review we discuss recent discoveries in the NRF2 field that were enabled by advances in genomic and computational biology methods and outline possible future endeavors.

AB - Heterotrophs are regularly exposed to harmful xenobiotics from their diet and from environmental exposure. As such, systems to counteract the negative consequences brought on by this exposure have evolved since the dawn of heterotrophic nutrition. In mammalian cells, the CNC transcription factor, NRF2, plays a crucial role in counteracting the harmful effects of xenobiotics exposure. In response to increased electrophilic and oxidative stresses, NRF2 upregulates a wide array of target genes involved in various cellular processes to restore cellular homeostasis. Consequently, NRF2 activation is traditionally regarded as cancer preventative and cytoprotective. However, recent cancer genome sequencing efforts have uncovered a significant overrepresentation of somatic mutations that drive a sustained NRF2 activation phenotype in cancer. These mutations share similar features to somatic mutations in tumor suppressors and oncogenes, indicating that NRF2 activation is positively selected for during tumor growth. Additionally, genome wide determination of NRF2 target genes identified new target genes involved in proliferation and differentiation, metabolism, apoptosis, and DNA damage repair. NRF2 activation in cancer cells has also been correlated with chemo- and radio- therapy resistance and an overall poorer patient prognosis. Taken together, these characteristics of NRF2 function have established a need to better understand the full scope of the NRF2 regulatory network. In this review we discuss recent discoveries in the NRF2 field that were enabled by advances in genomic and computational biology methods and outline possible future endeavors.

KW - Cancer

KW - CUL3

KW - KEAP1

KW - NRF2

KW - Somatic mutations

UR - http://www.scopus.com/inward/record.url?scp=85016782538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016782538&partnerID=8YFLogxK

U2 - 10.1016/j.cotox.2016.09.003

DO - 10.1016/j.cotox.2016.09.003

M3 - Review article

VL - 1

SP - 37

EP - 45

JO - Current Opinion in Toxicology

JF - Current Opinion in Toxicology

SN - 2468-2020

ER -